Author:
Sturgeon Christopher M.,Cinel Bruno,Díaz-Marrero Ana R.,McHardy Lianne M.,Ngo Michelle,Andersen Raymond J.,Roberge Michel
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference22 articles.
1. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S (2004) Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73:39–85
2. Prudhomme M (2006) Novel checkpoint 1 inhibitors. Recent patents on anti-cancer drug discovery, 1,pp 55–68
3. Garber K (2005) New checkpoint blockers begin human trials. J Natl Cancer Inst 97:1026–8
4. Roberge M, Berlinck RGS, Xu L, Anderson HJ, Lim LY, Curman D, Stringer CM, Friend SH, Davies P, Vincent I, Haggarty SJ, Kelly MT, Britton R, Peirs E, Andersen RJ (1998) High-throughput assay for G2 checkpoint inhibitors and identification of the structurally novel compound isogranulatimide. Cancer Res 58:5701–6
5. Rundle NT, Xu L, Andersen RJ, Roberge M (2001) G2 DNA damage checkpoint inhibition and antimitotic activity of 13-hydroxy-15-oxozoapatlin. J Biol Chem 276:48231–6
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献